Doctoral · Biddeford, Maine

Is Pharmacy, Pharmaceutical Sciences, and Administration at University of New England worth it?

Medium confidence Medium confidence: 40–99 graduates behind the earnings figures.

The verdict · all families, in-state, half paid with loans

Pays back in time: graduates typically recover the cost in about 5.7 years.

Earnings 1 year after graduating: $125,617; Treasury AY2020-21, AY2021-22 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Earnings 4 years after graduating: $142,224; Treasury AY2017-2018, AY2018-2019 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Typical federal debt at graduation: $236,768; NSLDS pooled AY2022-23, AY2023-24 cohort
Typical borrowing (no graduate net price is published): $251k (likely $251k – $251k); AcadYr 2024-25, reported in IPEDS DCY2025-26
Earnings bump, year 4: $81k a year vs bachelor's graduates 4 years out in ME; 2023 ACS 5-year pooled, adjusted to 2024 dollars
Payback: 5.7 years (likely 4.7–7.0); Bump vs net cost plus loan interest
10-year net return: $54k (likely −$108k – $228k); Today's dollars
20-year net return: $1.04M (likely $679k – $1.40M); Today's dollars
Borrowers making progress / in default, 2 years in: not reported / ≤ 10%; NSLDS AY2016-17, AY2017-18 pooled cohorts measured in 2018-19, 2019-20

Scorecard reports no net price for graduate programs; cost is based on what graduates typically borrowed.